# Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B

> **NCT00307242** · PHASE4 · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 40 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Adefovir Dipivoxil

## Key facts

- **NCT ID:** NCT00307242
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06-17
- **Primary completion:** 2009-02
- **Final completion:** 2009-02-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307242, "Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00307242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*